News MIVI-TRUST Outcomes Strengthen Support Of Ocriplasmin For Vitreomacular Adhesion by OphthalmologyWeb • 2011/08/23 • 0 Comments Ocriplasmin may become the first pharmacologic option for patients with vitreomacular adhesion, according to two presentations here. Full Story →